Best Peptides for Cognitive Research: 2026 Scientific Overview

The Cognitive Research Peptide Class

The Cognitive & Neurological research peptide category at Advanced Peptide Science features five foundational compounds spanning five distinct CNS pharmacology mechanisms. The diverse mechanism coverage enables research-tool comparison across the major branches of CNS peptide pharmacology — from neurotrophic-factor pathway research to ion-channel-based excitability modulation to multi-factor neurotrophic supplementation. All compounds are supplied at 99%+ HPLC-verified purity with batch-specific Certificate of Analysis documentation available.

Semax: BDNF Pathway Modulation

Semax (Met-Glu-His-Phe-Pro-Gly-Pro, MW 813.9 Da) is a synthetic heptapeptide ACTH 4-7 analogue developed at the Russian Academy of Sciences. Supplied as lyophilized powder for nasal solution reconstitution, Semax research focuses on rapid BDNF upregulation in hippocampal and cortical neurons, plus modulation of serotonergic, dopaminergic, and cholinergic neurotransmitter systems.

Selank: GABA-A Pathway Modulation

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro, MW 751.9 Da) is the companion Russian neuropeptide to Semax, sharing the same nasal-solution delivery format. Selank research focuses on GABA-A receptor modulation, inhibition of enkephalin-degrading enzymes, and anxiolytic-pathway signalling distinct from benzodiazepine GABA-A allosteric modulation.

Dihexa: HGF/MET Synaptogenesis Pathway

Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide, MW 474.6 Da) is a small-molecule angiotensin IV analogue developed at Washington State University. Mechanism research focuses on potentiation of the HGF (hepatocyte growth factor) / c-Met receptor cascade for synaptogenesis — a pathway operationally distinct from BDNF/TrkB-mediated synaptogenesis.

Cerebrolysin: Multi-Factor Neurotrophic Mixture

Cerebrolysin is unlike the other compounds in the category — a standardised porcine brain-derived neuropeptide mixture containing BDNF, NGF, CNTF, and GDNF plus 25% free amino acid content. Supplied in sealed glass ampules with refrigerated storage, the multi-factor preparation enables research into concurrent activation of multiple neurotrophic receptor systems.

PE-22-28: TREK-1 Channel Pharmacology

PE-22-28 (synthetic spadin analogue, MW ~800 Da) is the only TREK-1 channel blocker in the catalogue. The compound is a research tool for two-pore-domain potassium channel pharmacology, with applications in rapid-onset antidepressant mechanism research distinct from SSRI monoamine reuptake inhibition.

Mechanism Diversity as Research-Tool Framework

The five compounds together provide research-tool access to five fundamentally different CNS pharmacology mechanisms: receptor-mediated BDNF upregulation, GABA-A modulation, HGF/MET cascade potentiation, multi-factor neurotrophic receptor activation, and ion channel blockade. Comparative research across the compound set enables dissection of which CNS effects depend on which mechanism class — a research-tool framework for fundamental CNS peptide pharmacology.

Research Specifications

Semax	813.9 Da, ACTH 4-7 analogue, BDNF + neurotransmitter modulation
Selank	751.9 Da, tuftsin analogue, GABA-A + enkephalin pathway
Dihexa	474.6 Da, angiotensin IV analogue, HGF/MET synaptogenesis
Cerebrolysin	~21.4 kDa FPE fraction, porcine neuropeptide mixture (BDNF/NGF/CNTF/GDNF)
PE-22-28	~800 Da, spadin analogue, TREK-1 channel blocker
Category	Cognitive & Neurological

Frequently Asked Questions

Which cognitive research peptide is most appropriate for synaptogenesis research?

Dihexa (HGF/MET cascade) and Cerebrolysin (multi-factor neurotrophic mixture including BDNF) are the primary synaptogenesis research compounds in the category. The two engage distinct mechanism classes, making them complementary research tools.

How do nasal-solution compounds differ from injectable lyophilized peptides?

Semax and Selank are supplied as lyophilized powder for nasal solution reconstitution — engineered for intranasal absorption via the nasal/olfactory route. Other compounds in the category are supplied as injectable lyophilized powder or, in Cerebrolysin’s case, sterile ampule solution.

Can these compounds be combined in research?

Yes — combined research is common, particularly the Semax + Selank Russian-neuropeptide stack and combinations of single-mechanism compounds with multi-factor Cerebrolysin. The diverse mechanism coverage supports multi-pathway research frameworks.

Are these compounds approved for human use?

Advanced Peptide Science supplies all cognitive research compounds exclusively for in vitro and in vivo scientific research. Not for human consumption. Research use only.

---

For Research Use Only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.